Related Experiment Video
Updated: Nov 21, 2025

Optimization of a Quantitative Micro-neutralization Assay
Published on: December 14, 2016
Reconstitution of Oseltamivir Capsules for Pediatric Use on a Long-Term Cruise: A Treatment Option
Yoshihiro Aoki1, Liliana Del Carmen Amaya Dimas2, Katsuhiko Kitazawa3
1Department of Emergency and Critical Care Medicine, Aizawa Hospital, Nagano, Japan; Department of Pediatrics, Aizawa Hospital, Nagano, Japan.
Insights
Decapsulating oral oseltamivir (Tamiflu) offers a safe method for treating pediatric influenza on cruise ships. This approach ensures correct dosing for children, aiding in early recovery and preventing disease spread during voyages.
Area of Science:
- Virology
- Public Health
- Pediatrics
Background:
- Influenza poses significant risks for cruise ship passengers, particularly children and the elderly.
- Cruise ship environments can facilitate rapid transmission of infectious diseases like influenza.
- Standard oseltamivir capsules are not formulated for appropriate pediatric dosing.
Observation:
- Two siblings contracted influenza during a world cruise.
- They were successfully treated with decapsulated oseltamivir, prepared by their mother.
- The medication was administered orally using a syringe after suspending the powder in water.
Findings:
- Both pediatric patients recovered fully without complications.
- The decapsulation method allowed for accurate, age-appropriate dosing.
- This approach proved effective in a real-world cruise ship scenario.
Implications:
- Decapsulating oseltamivir is a viable and safe strategy for pediatric influenza treatment in resource-limited environments.
- This method can help control influenza transmission on cruise voyages.
- It offers a practical solution for achieving correct pediatric dosing when standard formulations are inadequate.
Abstract:
Influenza is a concerning disease in terms of risk management for cruise passengers during a voyage. Currently, cruise passengers include children in addition to elderly people. Oral oseltamivir can be used to treat pediatric influenza. In addition, early antiviral treatment may reduce the spread of influenza on board. However, the capsule form of oseltamivir is not of the recommended dosage for children. In this report, we describe 2 siblings who acquired influenza during travel on a world cruise ship and were treated with decapsulated oseltamivir. The siblings' mother was instructed to decapsulate a 75 mg oseltamivir capsule, suspend the powder in 15 mL of water (5 mg·mL-1), stir well, and administer the required amount of medicine orally to each patient using a syringe. Both patients recovered successfully with no complications. The presented case suggests that suspending decapsulated oseltamivir in water and measuring the required amount with a syringe for orally administration to children with influenza can be a safe treatment strategy in resource-limited settings.
More Related Videos
11:48Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
Related Concept Videos
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Inhaled Medications
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...